DaVita Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by DaVita HealthCare Partners Inc. on June 17, 2014. The report details the results of the Company's annual meeting of stockholders held on that date in Denver, Colorado, and the approval of amendments to the Company's equity incentive plan.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance matters and stockholder voting results.
Material Changes and Voting Results
At the annual meeting, 181,539,660 shares (84.75% of outstanding shares) were represented. The following matters were voted upon:
- Election of Directors: All ten nominees were elected. Voting results ranged from approximately 93.7% to 97.9% "For" votes.
- Ratification of Auditors: Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for 2014.
- Executive Compensation: The advisory vote on executive compensation was approved by a majority of shares represented.
- Equity Plan Amendment: Stockholders approved the amendment and restatement of the DaVita Inc. 2011 Incentive Award Plan. This amendment permits the grant of performance-based awards tied to non-financial performance targets. The plan authorizes the issuance of up to 47,178,338 shares of common stock.
- Stockholder Proposal: A stockholder proposal regarding the board chairmanship was defeated, receiving less than a majority of the votes cast.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management outlook, or discuss specific risks or contingencies. The primary corporate action noted is the expansion of the 2011 Incentive Award Plan to include non-financial performance criteria, which the Board believes are critical to the Company's performance.
Key Facts for Investor Verification
- Verify the specific non-financial performance targets added to the 2011 Incentive Award Plan by reviewing the Definitive Proxy Statement (Schedule 14A) filed on April 28, 2014.
- Confirm the total number of shares available for issuance under the amended 2011 Plan (47,178,338) and the rules regarding share recycling for forfeited awards.
- Note the significant "Against" vote (approximately 7.5 million shares) on the stockholder proposal regarding board chairmanship, indicating active dissent on governance structure.
- Review the full text of the 2011 Incentive Award Plan (Exhibit 10.1) for detailed terms regarding equity-based compensation.